A PROGNOSZTIKAI TENYEZOK JELENTOSEGE ES OSSZEFUGGESEIK AZ ELOREHALADOTT STADIUMBELI HEREDAGANATOK SEBESZI KEZELESEBEN

Translated title of the contribution: Significance and correlation of different prognostic factors in the surgical management of germ cell testicular tumors in advanced stages

L. Kisbenedek, I. Bodrogi, P. Szeldeli, M. Baki, P. Tenke, J. Horti, L. Vincze

Research output: Contribution to journalArticle

Abstract

The authors - analysing the data of 81 salvage retroperitoneal lymphnode dissections - have examined the role of different surgical-pathological factors in the surgical management of patients with advanced testicular tumors (UICC stage II/B bulky and stage III). From 100 men with advanced germ cell testicular tumors have been treated with 4-5 courses of inductive chemotherapy were referred to salvage retroperitoneal lymphnode dissection with complete and partial remission too. After evaluating their data, they concluded, that beside the well known primary role of the residual histology (active cancer in the retroperitoneal rest) in prognosis, they proved, the role of retroperitoneal lymphnode dissection was far more decisive in the treatment of patients entered partial remission after inductive chemotherapy. They found a 17% incidence of active cancer in the retroperitoneum of complete remission cases too. In contrast to tile general belief, they have proved, if a patient needs more than 4 courses of combination chemotherapy, or mainly if it has to be completed by a second, or a third line combination to reach a clinical partial remission in the retroperitoneum, it was a bad prognostic sign, pointing to a chemoresistant retroperitoneal rest.

Original languageHungarian
Pages (from-to)331-339
Number of pages9
JournalMagyar Urologia
Volume6
Issue number4
Publication statusPublished - 1994

Fingerprint

Dissection
Drug Therapy
Testicular Neoplasms
Combination Drug Therapy
Neoplasms
Histology
Incidence
Testicular Germ Cell Tumor
Therapeutics

ASJC Scopus subject areas

  • Urology

Cite this

A PROGNOSZTIKAI TENYEZOK JELENTOSEGE ES OSSZEFUGGESEIK AZ ELOREHALADOTT STADIUMBELI HEREDAGANATOK SEBESZI KEZELESEBEN. / Kisbenedek, L.; Bodrogi, I.; Szeldeli, P.; Baki, M.; Tenke, P.; Horti, J.; Vincze, L.

In: Magyar Urologia, Vol. 6, No. 4, 1994, p. 331-339.

Research output: Contribution to journalArticle

Kisbenedek, L. ; Bodrogi, I. ; Szeldeli, P. ; Baki, M. ; Tenke, P. ; Horti, J. ; Vincze, L. / A PROGNOSZTIKAI TENYEZOK JELENTOSEGE ES OSSZEFUGGESEIK AZ ELOREHALADOTT STADIUMBELI HEREDAGANATOK SEBESZI KEZELESEBEN. In: Magyar Urologia. 1994 ; Vol. 6, No. 4. pp. 331-339.
@article{41f0a7ad9e4c46ca8ba541f242344c0d,
title = "A PROGNOSZTIKAI TENYEZOK JELENTOSEGE ES OSSZEFUGGESEIK AZ ELOREHALADOTT STADIUMBELI HEREDAGANATOK SEBESZI KEZELESEBEN",
abstract = "The authors - analysing the data of 81 salvage retroperitoneal lymphnode dissections - have examined the role of different surgical-pathological factors in the surgical management of patients with advanced testicular tumors (UICC stage II/B bulky and stage III). From 100 men with advanced germ cell testicular tumors have been treated with 4-5 courses of inductive chemotherapy were referred to salvage retroperitoneal lymphnode dissection with complete and partial remission too. After evaluating their data, they concluded, that beside the well known primary role of the residual histology (active cancer in the retroperitoneal rest) in prognosis, they proved, the role of retroperitoneal lymphnode dissection was far more decisive in the treatment of patients entered partial remission after inductive chemotherapy. They found a 17{\%} incidence of active cancer in the retroperitoneum of complete remission cases too. In contrast to tile general belief, they have proved, if a patient needs more than 4 courses of combination chemotherapy, or mainly if it has to be completed by a second, or a third line combination to reach a clinical partial remission in the retroperitoneum, it was a bad prognostic sign, pointing to a chemoresistant retroperitoneal rest.",
keywords = "Prognosis, Retroperitoneal lymphnode dissection, Testicular tumors",
author = "L. Kisbenedek and I. Bodrogi and P. Szeldeli and M. Baki and P. Tenke and J. Horti and L. Vincze",
year = "1994",
language = "Hungarian",
volume = "6",
pages = "331--339",
journal = "Magyar Urologia",
issn = "0864-8921",
publisher = "Society of Hungarian Urological Surgeons",
number = "4",

}

TY - JOUR

T1 - A PROGNOSZTIKAI TENYEZOK JELENTOSEGE ES OSSZEFUGGESEIK AZ ELOREHALADOTT STADIUMBELI HEREDAGANATOK SEBESZI KEZELESEBEN

AU - Kisbenedek, L.

AU - Bodrogi, I.

AU - Szeldeli, P.

AU - Baki, M.

AU - Tenke, P.

AU - Horti, J.

AU - Vincze, L.

PY - 1994

Y1 - 1994

N2 - The authors - analysing the data of 81 salvage retroperitoneal lymphnode dissections - have examined the role of different surgical-pathological factors in the surgical management of patients with advanced testicular tumors (UICC stage II/B bulky and stage III). From 100 men with advanced germ cell testicular tumors have been treated with 4-5 courses of inductive chemotherapy were referred to salvage retroperitoneal lymphnode dissection with complete and partial remission too. After evaluating their data, they concluded, that beside the well known primary role of the residual histology (active cancer in the retroperitoneal rest) in prognosis, they proved, the role of retroperitoneal lymphnode dissection was far more decisive in the treatment of patients entered partial remission after inductive chemotherapy. They found a 17% incidence of active cancer in the retroperitoneum of complete remission cases too. In contrast to tile general belief, they have proved, if a patient needs more than 4 courses of combination chemotherapy, or mainly if it has to be completed by a second, or a third line combination to reach a clinical partial remission in the retroperitoneum, it was a bad prognostic sign, pointing to a chemoresistant retroperitoneal rest.

AB - The authors - analysing the data of 81 salvage retroperitoneal lymphnode dissections - have examined the role of different surgical-pathological factors in the surgical management of patients with advanced testicular tumors (UICC stage II/B bulky and stage III). From 100 men with advanced germ cell testicular tumors have been treated with 4-5 courses of inductive chemotherapy were referred to salvage retroperitoneal lymphnode dissection with complete and partial remission too. After evaluating their data, they concluded, that beside the well known primary role of the residual histology (active cancer in the retroperitoneal rest) in prognosis, they proved, the role of retroperitoneal lymphnode dissection was far more decisive in the treatment of patients entered partial remission after inductive chemotherapy. They found a 17% incidence of active cancer in the retroperitoneum of complete remission cases too. In contrast to tile general belief, they have proved, if a patient needs more than 4 courses of combination chemotherapy, or mainly if it has to be completed by a second, or a third line combination to reach a clinical partial remission in the retroperitoneum, it was a bad prognostic sign, pointing to a chemoresistant retroperitoneal rest.

KW - Prognosis

KW - Retroperitoneal lymphnode dissection

KW - Testicular tumors

UR - http://www.scopus.com/inward/record.url?scp=0028619964&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028619964&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0028619964

VL - 6

SP - 331

EP - 339

JO - Magyar Urologia

JF - Magyar Urologia

SN - 0864-8921

IS - 4

ER -